Patients expecting medication alone to produce significant weight loss often report disappointment, even when the injection is functioning optimally
However, landmark analysis, adjusting the cohort selection period to 2, 6, 9, and 12 months post-transplant, demonstrated consistent beneficial effects of GLP-1 RAs on all-cause mortality, MACEs, and MAKEs (Supplemental Table 13)
Timing of Tirzepatide Nausea: When Symptoms Peak Most people experience nausea within the first few hours after injecting tirzepatide, with symptoms typically peaking between two and four hours post-injection
For those uninsured, discussions involving accessible options unfold, ensuring no treatment barrier exists
Risk for cancer after bariatric surgery compared with the general population: a nationwide matched cohort study